Prolactinoma risk factors: Difference between revisions
No edit summary |
|||
Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
[[Prolactinoma]] may occur as part of a hereditary disorder called multiple endocrine neoplasia type 1 (MEN 1), so patients with MEN 1 are at incresead risk for prolactinoma. So patients with any of these syndromes are at increased risk for prolactinoma. | [[Prolactinoma]] may occur as part of a hereditary disorder called multiple endocrine neoplasia type 1 (MEN 1), so patients with MEN 1 are at incresead risk for prolactinoma. So patients with any of these syndromes are at increased risk for prolactinoma. | ||
==Risk factors== | ==Risk factors== | ||
[[Prolactinoma]] may occur as part of a hereditary disorder called multiple endocrine neoplasia type 1 (MEN 1), so patients with MEN 1 are at increased risk for prolactinoma. A minority of tumors are associated with: | [[Prolactinoma]] may occur as part of a hereditary disorder called multiple endocrine neoplasia type 1 (MEN 1), so patients with MEN 1 are at increased risk for prolactinoma. A minority of tumors are associated with: |
Revision as of 18:49, 9 September 2015
Prolactinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Prolactinoma risk factors On the Web |
American Roentgen Ray Society Images of Prolactinoma risk factors |
Risk calculators and risk factors for Prolactinoma risk factors |
Overview
Prolactinoma may occur as part of a hereditary disorder called multiple endocrine neoplasia type 1 (MEN 1), so patients with MEN 1 are at incresead risk for prolactinoma. So patients with any of these syndromes are at increased risk for prolactinoma.
Risk factors
Prolactinoma may occur as part of a hereditary disorder called multiple endocrine neoplasia type 1 (MEN 1), so patients with MEN 1 are at increased risk for prolactinoma. A minority of tumors are associated with:
- Multiple endocrine neoplasia type I (MEN I)
- Carney complex
- McCune-Albright Syndrome
- MEN like syndrome ( CKDN1B loss of function)[1]
So patients with any of these syndromes are at increased risk for prolactinoma.